Abstract
Two series of novel dendritic ligands based on (1 S,2 R)-norephedrine have been designed and synthesized, and incorporated into Ru(II) complexes as catalysts for asymmetric transfer hydrogenation. Some dendritic catalysts demonstrated dendritic acceleration effects as well as high catalytic activity and good enantioselectivity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
